Welcome to our dedicated page for BRENNTAG SE news (Ticker: BNTGF), a resource for investors and traders seeking the latest updates and insights on BRENNTAG SE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BRENNTAG SE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BRENNTAG SE's position in the market.
Brenntag, the leading global distributor of chemicals and ingredients, reported strong Q1 2021 results, achieving sales of 3,132.5 million EUR. Operating gross profit rose by 7.4% to 764.5 million EUR, while operating EBITDA increased 20.7% to 300.3 million EUR. Despite these gains, earnings per share decreased to 0.63 EUR due to extraordinary provisions related to a tax audit. Brenntag maintains its full-year operating EBITDA guidance between 1.08 to 1.18 billion EUR, with both divisions contributing to growth.
FAQ
What is the market cap of BRENNTAG SE (BNTGF)?
